Code usapeptidevendors: 25% off everything at · Purgo Labs

Related brand · disclosed
USA Peptide VendorsIndependent vendor reviews
Purgo Labsusapeptidevendors

Try

Multi-peptide blend · 2 components

GLP-3 R + Eloralintide, component by component

Vial with 10mg GLP-3 R (Purgo's retatrutide-type triple agonist) and 2mg eloralintide.

Multi-Peptide BlendsGLP-3 R / Elora BlendUpdated 2026-11-09

Per-vial contents

Combination untested. Pairs an incretin triple agonist with an amylin agonist, mirroring the GLP-1 + amylin combinations in clinical development.
Original illustration for GLP-3 R + Eloralintide Blend research notes: abstract molecular artwork in orange and teal
Original illustration by USA Peptide Vendors; artistic, not a structural model.

What each component does on its own

Evidence level: Components only: no study has tested this combination. All mechanism maps

GLP-3 R + Eloralintide Blend mechanism diagramEach component's own reported mechanism, side by side. Targets: Retatrutide: GIPR, Eloralintide: Amylin receptor. : . Effect reported for that component alone: Calorie intake ↓, Food intake ↓.GLP-3 R + Eloralintide Blend mechanism mapEach component's own reported mechanism, side by sideGLP-3 R + Eloralintide Blend2-component blendRetatrutide: GIPRGIP receptor [1]Eloralintide: Amylin receptorcalcitonin receptor + RAMP [2]Calorie intake ↓GIPR + GLP-1R, mice [1]Food intake ↓[2]Evidence: Components only: no study has tested this combination. Numbers in brackets referto the cited sources.usapeptidevendors.com · Research Use OnlyCOMPONENT → REPORTED TARGETEFFECT REPORTED FOR THAT COMPONENT ALONE
Each row comes from studies of that peptide on its own. Whether the blend behaves like the sum of its parts has not been studied. Open SVG
  1. Coskun T et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss. Cell Metab. 2022;34:1234–1247.
  2. Panou T et al. New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus. Diabetes Ther. 2026;17:1613-1638.

Blend-specific checks

  • Ask for net content per component: Retatrutide (10mg), Eloralintide (2mg). A single purity figure for the vial doesn't cover each peptide.

FAQ

What is GLP-3 R + Eloralintide Blend?

Vial with 10mg GLP-3 R (Purgo's retatrutide-type triple agonist) and 2mg eloralintide. Pairs an incretin triple agonist with an amylin agonist, mirroring the GLP-1 + amylin combinations in clinical development.

What's in GLP-3 R + Eloralintide Blend?

Retatrutide 10mg, Eloralintide 2mg. No published study has tested this exact combination; each component's evidence is separate.

Where can US labs buy GLP-3 R + Eloralintide Blend?

Purgo Labs stocks it as “GLP-3 R / Elora Blend”; code usapeptidevendors takes 25% off at checkout. This page also lists the best-documented second vendor from our 112-vendor directory.

Is research-grade GLP-3 R + Eloralintide Blend for human use?

No. Vendor material is sold for Research Use Only, not for human or veterinary use.